Name:
Bacillus amyloliquefaciens (ex Fukumoto 1943) Priest et al. 1987 emend. Wang et al. 2008
DSM No.:
1062
Strain designation:
RTCI 306
Other collection no.
or WDCM no.:
IFO 3034,OUT 8108,NBRC 3034
Country:
country of origin unknown
Date of sampling:
before 27.04.1977
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- OUT, 8108 (Bacillus subtilis) <- IFO <- Ch. Matsumura, RTCI 306
Cultivation conditions:
Medium 1 , 30°C
Complete DSMZ Media List
Summary and
additional information:
<- OUT, 8108 (Bacillus subtilis) <- IFO <- Ch. Matsumura, RTCI 306. Taxonomy/description (696). Produces inhibitors for glycoside hydrolases (Brit. Pat. 155,409). (Medium 1, 30°C).
Literature:
696, 2277
Risk group:
1 (classification according to German TRBA)
Supplied as:
Delivery form Prices
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
DSM1062
Bacillus amyloliquefaciens (ex Fukumoto 1943) Priest et al. 1987 emend. Wang et al. 2008
DSM No.:
1062
Strain designation:
RTCI 306
Other collection no.
or WDCM no.:
IFO 3034,OUT 8108,NBRC 3034
Country:
country of origin unknown
Date of sampling:
before 27.04.1977
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- OUT, 8108 (Bacillus subtilis) <- IFO <- Ch. Matsumura, RTCI 306
Cultivation conditions:
Medium 1 , 30°C
Complete DSMZ Media List
Summary and
additional information:
<- OUT, 8108 (Bacillus subtilis) <- IFO <- Ch. Matsumura, RTCI 306. Taxonomy/description (696). Produces inhibitors for glycoside hydrolases (Brit. Pat. 155,409). (Medium 1, 30°C).
Literature:
696, 2277
Risk group:
1 (classification according to German TRBA)
Supplied as:
Delivery form Prices
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
DSM1062
